Amanda C. LaRue

Dr. Amanda C. LaRue


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 April 2019 in Frontiers in Psychiatry
Verified
Journal Article
Open access
PDF file
RKRyan R. Kelly
Ryan R. Kelly
LMLindsay T. McDonald
Lindsay T. McDonald
NJNathaniel R. Jensen
Nathaniel R. Jensen
SSSara J. Sidles
Sara J. Sidles
ALAmanda C. LaRue
Amanda C. LaRue
The significant biochemical and physiological effects of psychological stress are beginning to be recognized as exacerbating common diseases, including osteoporosis. This review discusses the current evidence for psychological stress-associated mental health disorders as risk factors for osteoporosis, the mechanisms that may link these conditions, and potential implications for treatment. Traditional, alternative, and adjunctive therapies are discussed. This review is not intended to provide therapeutic recommendations, but, rather, the goal of this review is to delineate potential interactions of psychological stress and osteoporosis and to highlight potential multi-system implications of pharmacological interventions. Review of the current literature identifies several potentially overlapping mechanistic pathways that may be of interest (e.g., glucocorticoid signaling, insulin-like growth factor signaling, serotonin signaling) for further basic and clinical research. Current literature also supports the potential for cross-effects of therapeutics for osteoporosis and mental health disorders. While studies examining a direct link between osteoporosis and chronic psychological stress are limited, the studies reviewed herein suggest that a multi-factorial, personalized approach should be considered for improved patient outcomes in populations experiencing psychological stress, particularly those at high-risk for development of osteoporosis.

30 November 2020 in Frontiers in Psychology
Verified
Journal Article
Open access
PDF file
RKRyan R. Kelly
Ryan R. Kelly
SSSara J. Sidles
Sara J. Sidles
ALAmanda C. LaRue
Amanda C. LaRue
Neurological diseases, particularly in the context of aging, have serious impacts on quality of life and can negatively affect bone health. The brain-bone axis is critically important for skeletal metabolism, sensory innervation, and endocrine cross-talk between these organs. This review discusses current evidence for the cellular and molecular mechanisms by which various neurological disease categories, including autoimmune, developmental, dementia-related, movement, neuromuscular, stroke, trauma, and psychological, impart changes in bone homeostasis and mass, as well as fracture risk. Likewise, how bone may affect neurological function is discussed. Gaining a better understanding of brain-bone interactions, particularly in patients with underlying neurological disorders, may lead to development of novel therapies and discovery of shared risk factors, as well as highlight the need for broad, whole-health clinical approaches toward treatment.

1 January 2015 in World Journal of Stem Cells
Verified
Journal Article
Open access
YXYing Xiong
Ying Xiong
LMLindsay T McDonald
Lindsay T McDonald
DRDayvia L Russell
Dayvia L Russell
RKRyan R Kelly
Ryan R Kelly
KWKatie R Wilson
Katie R Wilson
ALAmanda C. LaRue
Amanda C. LaRue
Hematopoietic stem cell-derived adipocytes and fibroblasts in the tumor microenvironment

1 May 2015 in Neoplasia
Verified
Journal Article
Open access
LMLindsay T. McDonald
Lindsay T. McDonald
DRDayvia L. Russell
Dayvia L. Russell
RKRyan R. Kelly
Ryan R. Kelly
YXYing Xiong
Ying Xiong
AMAnjan Motamarry
Anjan Motamarry
ALAmanda C. LaRue
Amanda C. LaRue
Targeting the tumor microenvironment is critical toward improving the effectiveness of cancer therapeutics. Cancer-associated fibroblasts (CAFs) are one of the most abundant cell types of the tumor microenvironment, playing an important role in tumor progression. Multiple origins for CAFs have been proposed including resident fibroblasts, adipocytes, and bone marrow. Our laboratory previously identified a novel hematopoietic stem cell (HSC) origin for CAFs; however, the functional roles of HSC-derived CAFs (HSC-CAFs) in tumor progression have not yet been examined. To test the hypothesis that HSC-CAFs promote tumor progression through contribution to extracellular matrix (ECM) and paracrine production of pro-angiogenic factors, we developed a method to isolate HSC-CAFs. HSC-CAFs were profiled on the basis of their expression of hematopoietic and fibroblastic markers in two murine tumor models. Profiling revealed production of factors associated with ECM deposition and remodeling. Functional in vivo studies showed that co-injection of HSC-CAFs with tumor cells resulted in increased tumor growth rate and significantly larger tumors than tumor cells alone. Immunohistochemical studies revealed increased blood vessel density with co-injection, demonstrating a role for HSC-CAFs in tumor vascularization. Mechanistic in vitro studies indicated that HSC-CAFs play a role in producing vascular endothelial growth factor A and transforming growth factor-β1 in endothelial tube formation and patterning. In vitro and in vivo findings suggest that HSC-CAFs are a critical component of the tumor microenvironment and suggest that targeting the novel HSC-CAF may be a promising therapeutic strategy.

31 July 2010 in Experimental Hematology
Verified
Journal Article
Closed access
PDF file
MMMeenal Mehrotra
Meenal Mehrotra
MRMichael Rosol
Michael Rosol
MOMakio Ogawa
Makio Ogawa
ALAmanda C. LaRue
Amanda C. LaRue

1 January 2013 in Blood Cells, Molecules, and Diseases
Verified
Journal Article
Closed access
MMMeenal Mehrotra
Meenal Mehrotra
CWChristopher R. Williams
Christopher R. Williams
MOMakio Ogawa
Makio Ogawa
ALAmanda C. LaRue
Amanda C. LaRue